CARINA BIOTECH
Carina Biotech is a biotechnology company that develops cellular immunotherapies, particularly to treat childhood cancers. They research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. They develop technologies to improve access to and infiltration of solid cancers and enhance CAR-T cell manufacturing.
CARINA BIOTECH
Industry:
Biotechnology Manufacturing Product Research
Founded:
2016-01-01
Address:
Adelaide, South Australia, Australia
Country:
Australia
Website Url:
http://www.carinabiotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Official Site Inspections
http://www.carinabiotech.com Semrush global rank: 8.44 M Semrush visits lastest month: 312
- Host name: syn02he.syd5.hostyourservices.net
- IP address: 43.250.142.99
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Carina Biotech"
Board and Management - Carina Biotech
Management Dr Deborah Rathjen Chief Executive Officer & Managing Director Professor Shaun McColl Vice President, Chemokine Receptor Platform Dr Jose Iglesias Chief Medical Officer โฆSee details»
CAR-T THERAPY - Carina Biotech
Carina Biotech - Crunchbase Investor Profile
Contact Email [email protected]; Carina Biotech is a biotechnology company that develops cellular immunotherapies, particularly to treat โฆSee details»
Carina Biotech Information - RocketReach
Carinabiotech.com; 2 314603XXXX; 314428XXXX; Annabell Leske Project Manager at Carina Biotech Adelaide, SA, AU View. 1 carinabiotech.com; View Similar People. Related โฆSee details»
Carina Biotech - Company Profile - Tracxn
Mar 1, 2025 Email ID: *****@carinabiotech.com; Key Metrics. Total Funding. $10.6M in 2 rounds. Latest Funding Round. Series A, Aug 18, 2022, $5.22M. Investors. Minderoo โฆSee details»
Carina Biotech Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
For more information please contact: Deborah Rathjen, PhD CEO & Managing Director Carina Biotech +61 418 160 425 [email protected] Rudi Michelson Monsoon โฆSee details»
Carina Biotech - LinkedIn
Carina Biotech | 2,681 followers on LinkedIn. We are creating a future that defeats cancer. | Carina Biotech An Australian clinical stage immunotherapy company established to research โฆSee details»
Carina Biotech - Craft
Carina Biotech is a company specializing in cellular immunotherapies. It develops a range of chimeric antigen receptor T cell (CAR-T) technologies to treat solid cancers in vitro including โฆSee details»
CARINA BIOTECH LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CARINA BIOTECH LIMITED of Mawson Lakes, SOUTH AUSTRALIA. Get the latest business insights โฆSee details»
Carina Biotech 2025 Company Profile: Valuation, โฆ
Information on valuation, funding, cap tables, investors, and executives for Carina Biotech. Use the PitchBook Platform to explore the full profile.See details»
Carina Biotech Company Profile | Management and Employees List โฆ
[email protected]: Carina Biotech Top Competitors. Company Employees Revenue Top technologies; HaemaLogiX Pty Ltd. 12: $5.8 M: Prescient Therapeutics Ltd. 17: $6.5 M: Active โฆSee details»
Carina Biotech - Products, Competitors, Financials, Employees ...
Carina Biotech is a clinical stage immunotherapy company focused on the development of CAR-T therapies for solid cancers. Use the CB Insights Platform to explore Carina Biotech's full profile.See details»
Dr Leanna Read | Board & Management - Carina Biotech
Dr Leanna Read Chair. Dr Leanna Read has broad-ranging executive, board and investment experience in technology-based enterprises, particularly biotechnology, including founding a โฆSee details»
Carina Biotech to Present Preclinical Data Evaluating
Aug 21, 2023 Deborah Rathjen, PhD CEO & Managing Director Carina Biotech +61 418 160 425 [email protected]: Rudi Michelson Monsoon Communications +61 (0)3 9620 3333See details»
Carina Biotech Receives FDA โSafe to Proceedโ Letter for IND ...
Jan 23, 2023 CARINA BIOTECH PTY LTD. Receives greenlight from the FDA for Phase 1/2a clinical trial of CNA3103. On track to commence patient enrollment during the first half 2023See details»
Carina Biotech Ltd. (Carina Biotech Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ โฆ
For more information please contact: Deborah Rathjen, PhD CEO & Managing Director Carina Biotech +61 418 160 425 [email protected] Rudi Michelson Monsoon โฆSee details»
Federal government announces support for cutting-edge, AI- and โฆ
1 day ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for โฆSee details»
PRESS RELEASE: Carina Biotech Doses First Patient in Phase 1/2a ...
Dec 19, 2023 ADELAIDE, AUSTRALIA, December 19, 2023 Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy First patient dosed in โฆSee details»
Establishing Canadaโs first large-scale bioinnovation centre
3 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and โฆSee details»
Poster Presentations and Publications - Carina Biotech
May 4, 2023 AACR 2023 Development and in vitro validation of an LGR-5 targeting CAR-T against colorectal cancer. Veronika Bandara Session Category: Immunology Session Title: โฆSee details»